Fig. 6From: Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader–Willi syndrome: a one-year retrospective cohort studyForest plot of multi-factor logistic regression analysis of the potential factors in exacerbating OAHI in the rhGH treatment group. PWS genotype, rhGH treatment, IGF-1 z-score, IGFBP-3, obesity and overweight, and W/H z-score did not result in aggravating OAHIBack to article page